Document is current
Any future updates will be listed below
-
Authors
Sahin, Sezgin
Acari, Ceyhun
Sonmez, Hafize Emine
Kilic, Fatma Zehra
Sag, Erdal
Dundar, Hatice Adiguzel
Adrovic, Amra
Demir, Selcan
Barut, Kenan
Bilginer, Yelda
Sozeri, Betul
Unsal, Erbil
Ozen, Seza
Kasapcopur, Ozgur http://orcid.org/0000-0002-1125-7720
-
Funding
Funding for this research was provided by:
AbbVie
- License Information
-
More Information
Article History
Received: 8 January 2021
Accepted: 13 June 2021
First Online: 23 August 2021
Declarations
:
: Because of the retrospective nature of the study, obtaining written informed consent from the patients was not required. Ethics committee approval (date/no.: 03 October 2017/D-01) was obtained from the Istanbul University-Cerrahpasa, Ethics Committee of Clinical Trials.
: Not applicable.
: S.S. received a research grant from AbbVie.C.A. received a research grant from AbbVie.H.E.S. received a research grant from AbbVie.F.Z.K. received a research grant from AbbVie.E.S. received a research grant from AbbVie.H.A.D. received a research grant from AbbVie.A.A. received a research grant from AbbVie.S.D. received a research grant from AbbVie.K.B. received a research grant from AbbVie.Y.B. received a research grant from AbbVie.B.S. received research grant, consulting fee and/or speaker fee from AbbVie, Pfizer, Roche, Novartis, and Celltrion.E.U. received research grant and consulting fee from Novartis, AbbVie, Roche, and Kocak Pharma.S.O. received research grant and consulting fee from Novartis and speaker fee from Roche and SOBI.O.K. received a research grant from AbbVie.
